Drop in relapse rate of MS by combination therapy of three different phosphodiesterase inhibitors

Multiple Sclerosis

Volumn 6, Issue 1, 2000, Pages 56-58

  Suzumura, Akio ^a   Nakamuro, Takuya ^a   Tamaru, Tsukasa ^a   Takayanagi, Tetsuya ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Multiple sclerosis; Phosphodiesterase inhibitor; Relapse; TNF

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PREDNISOLONE; PROPENTOFYLLINE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA; VINPOCETINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEMYELINATION; DISABILITY; DOSE RESPONSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NAUSEA; RELAPSE;

EID: 0034103264     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245800678827455     Document Type: Article

References (10)

1. Selmaj KW, Raine CS, Canella B, Brosnan CF. (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87: 949-953.
2. Selmaj KW, Raine CS, Gross AH. (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30: 697-700.
3. Strieter RM et al. (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 155: 1230-1236.
4. Suzumura A, Sawada M. (1999) Effects of vesnarinone on activation of murine microglia. Life Science 64: 1197-1203.
5. Yoshikawa M, Suzumura A, Tamaru T, Takayanagi T. (1999) Effects of phosphodiesterase inhibitors on microglia. Multiple Sclerosis 5: 126-133.
6. Suzumura A, Ito A, Yoshikawa M, Sawada M. (1999) Ibudilast suppresses TNFα production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res, 837: 203-212.
7. Sommer N et al. (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med 1: 244-248.
8. Tamaru T, Suzumura A, Takayanagi T. (1998) Inhibitory effects of phosphodiesterase inhibitors on experimental autoimmune encephalomyelitis. Neuroimmunol 6: 154-155.
9. Lacor M et al. (1994) cAMP upregulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int Immunol 6: 1333-1343.
10. Weber F et al. (1998) Synergistic immunomodulatory effects of interferon-β1b and the phosphodiesterase inhibitor pentoxifylline in patients with relapsing-remitting multiple sclerosis. Ann Neurol 44: 27-34.